Zoetis (ZTS) EBITDA (2012 - 2026)

Zoetis (ZTS) has reported EBITDA for 15 consecutive years, with $837.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, EBITDA fell 10.0% year-over-year to $837.0 million in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 6.12% decrease from a year earlier, with the FY2025 full-year figure at $3.8 billion, up 2.95% from the prior year.
• EBITDA was $837.0 million for Q2 2026 at Zoetis, up from $697.0 million in the prior quarter.
• Over five years, EBITDA peaked at $930.0 million in Q2 2025 and troughed at -$212.0 million in Q4 2024.
• A 5-year average of $556.4 million and a median of $718.0 million in 2023 frame the typical range for EBITDA.
• The widest YoY moves for EBITDA: up 23.13% in 2024, down 15.22% in 2024.
• Over 5 years, EBITDA stood at -$187.0 million in 2022, then advanced by 1.6% to -$184.0 million in 2023, then retreated by 15.22% to -$212.0 million in 2024, then advanced by 8.96% to -$193.0 million in 2025, then jumped by 533.68% to $837.0 million in 2026.
• The last three EBITDA figures came in at $837.0 million (Q2 2026), $697.0 million (Q1 2026), and -$193.0 million (Q4 2025), per Business Quant data.